NCT01417520View on ClinicalTrials.gov

Clinical and Pathophysiological Investigations Into Erdheim Chester Disease

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

August 1, 2011

Study Completion Date

July 24, 2019

Conditions
MyelofibrosisGaucher DiseasePulmonary FibrosisHermansky-Pudlak Syndrome (HPS)Cancer
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Human Genome Research Institute (NHGRI)

NIH

NCT01417520 - Clinical and Pathophysiological Investigations Into Erdheim Chester Disease | Biotech Hunter | Biotech Hunter